Auransa

About:

A clinical stage drug development company who aims to invent novel drugs for hard-to-treat diseases using its proprietary AI platform

Website: https://www.auransa.com/

Twitter/X: auransainc

Top Investors: DCVC, AME Cloud Ventures, Lux Capital, 11.2 Capital, Future Shape

Description:

Auransa is a clinical stage drug development company who aims to invent high value, novel drugs for hard-to-treat diseases like cancer, auto-immune and neurological disorders using its proprietary AI platform and drug discovery expertise. The company's platform is used to understand biology of diseases at subtype level resolution, enabling it to predict compounds and targets of novel pharmacology for responder patient population. Current internal drug pipeline includes a first-in-class investigational new drug for cancer in clinical trials. Auransa has partnership with companies and institutions in the biopharma industry.